New phase3 trial for PSC (Gilead GS-9674)

Good news. I believe this is the second fully-regulatory body compliant phase3 clinical trial started for PSC (on-going norUDCA in Europe is the other one).

Gilead announced last year positive Phase 2 results (see here )

The new Phase3 clinical trial details:
Safety, Tolerability, and Efficacy of GS-9674 in Non-Cirrhotic Adults With Primary Sclerosing Cholangitis (PSC-Phase 3) (PSC-Phase 3)
Sponsor: Gilead Sciences
400 participants
Estimated Study Start Date: March 2019
Estimated Primary Completion Date: August 2022
Estimated Study Completion Date: August 2022

Great news…Any idea when Intercept will start phase III trials with OCA.

Great! Thanks for keeping us up-to date.